Literature DB >> 11601985

Evidence for simultaneous binding of dissimilar substrates by the Escherichia coli multidrug transporter MdfA.

O Lewinson1, E Bibi.   

Abstract

The mechanism by which multidrug transporters interact with structurally unrelated substrates remains enigmatic. Based on transport competition experiments, photoaffinity labeling, and effects on enzymatic activities, it was proposed in the past that multidrug transporters can interact simultaneously with a number of dissimilar substrate molecules. To study this phenomenon, we applied a direct binding approach and transport assays using the Escherichia coli multidrug transporter MdfA, which exports both positively charged (e.g., tetraphenylphosphonium, TPP(+)), zwitterionic (e.g., ciprofloxacin), and neutral (e.g., chloramphenicol) drugs. The interaction of MdfA with various substrates was examined by direct binding assays with the purified transporter. The immobilized MdfA binds TPP(+) in a specific manner, and all the tested positively charged substrates inhibit TPP(+) binding. Surprisingly, although TPP(+) binding is not affected by zwitterionic substrates, the neutral substrate chloramphenicol stimulates TPP(+) binding by enhancing its affinity to MdfA. In contrast, transport competition assays show inhibition of TPP(+) transport by chloramphenicol. We suggest that MdfA binds TPP(+) and chloramphenicol simultaneously to distinct but interacting binding sites, and the interaction between these two substrates during transport is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11601985     DOI: 10.1021/bi011040y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  Membrane topology of the multidrug transporter MdfA: complementary gene fusion studies reveal a nonessential C-terminal domain.

Authors:  Julia Adler; Eitan Bibi
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

2.  The Escherichia coli multidrug transporter MdfA catalyzes both electrogenic and electroneutral transport reactions.

Authors:  Oded Lewinson; Julia Adler; Gerrit J Poelarends; Piotr Mazurkiewicz; Arnold J M Driessen; Eitan Bibi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

3.  Ligand-transporter interaction in the AcrB multidrug efflux pump determined by fluorescence polarization assay.

Authors:  Chih-Chia Su; Hiroshi Nikaido; Edward W Yu
Journal:  FEBS Lett       Date:  2007-09-25       Impact factor: 4.124

4.  Characterization of the multidrug efflux regulator AcrR from Escherichia coli.

Authors:  Chih-Chia Su; Denae J Rutherford; Edward W Yu
Journal:  Biochem Biophys Res Commun       Date:  2007-07-17       Impact factor: 3.575

Review 5.  AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity.

Authors:  Edward W Yu; Julio R Aires; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

6.  A promiscuous conformational switch in the secondary multidrug transporter MdfA.

Authors:  Nir Fluman; Devora Cohen-Karni; Tali Weiss; Eitan Bibi
Journal:  J Biol Chem       Date:  2009-10-05       Impact factor: 5.157

7.  Tet(L) and tet(K) tetracycline-divalent metal/H+ antiporters: characterization of multiple catalytic modes and a mutagenesis approach to differences in their efflux substrate and coupling ion preferences.

Authors:  Jie Jin; Arthur A Guffanti; David H Bechhofer; Terry A Krulwich
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

8.  The Multidrug Transporter MdfA Deviates from the Canonical Model of Alternating Access of MFS Transporters.

Authors:  Eliane H Yardeni; Smriti Mishra; Richard A Stein; Eitan Bibi; Hassane S Mchaourab
Journal:  J Mol Biol       Date:  2020-08-26       Impact factor: 5.469

9.  Structural mechanism of the simultaneous binding of two drugs to a multidrug-binding protein.

Authors:  Maria A Schumacher; Marshall C Miller; Richard G Brennan
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

10.  Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa.

Authors:  Jocelyn K Middlemiss; Keith Poole
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.